A Drug-Drug Interaction Study to Assess the Effects of Multiple Doses of Mipomersen (200 mg SC) on Single-Dose Warfarin (25 mg) Pharmacodynamics and Pharmacokinetics in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Aug 2016
At a glance
- Drugs Mipomersen (Primary) ; Warfarin (Primary)
- Indications Hyperlipoproteinaemia type IIa; Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Kastle Therapeutics
- 27 Sep 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 27 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.